Study S003393

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09, a Long-acting Glucagon-like Peptide-1 Mimetic, in Healthy Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04354090
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: DOUBLE
Status: COMPLETED
Enrollment: 41
Start: 2018-04-26
Primary completion: 2018-12-27
Lead sponsor: Beijing Dongfang Biotech Co., Ltd.
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:JY09
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Incidence of adverse events and serious adverse events related to JY09 [Up to day 21]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.